Search results for bristol-myers squibb

Bristol-Myers Squibb Company (NYSE: BMY) and Avista Capital Partners, a leading private equity firm, announced today the parties have signed a defini read more »
Discuss   Add this link to...  Bury
Bristol-Myers Squibb Company (NYSE: BMY) and Gilead Sciences, Inc. (NASDAQ: GILD) today announced an agreement to commercialize ATRIPLA® (efavirenz 6 read more »
Discuss   Add this link to...  Bury
Bristol-Myers Squibb Company (NYSE: BMY) and Avista Capital Partners, a leading private equity firm, announced today that Avista has completed its ac read more »
Discuss   Add this link to...  Bury
Bristol-Myers Squibb Company (NYSE: BMY) today reported financial results for the fourth quarter and twelve months ended December 31, 2007 and revise read more »
Discuss   Add this link to...  Bury
Life and Style Expert Sandra Lee's Semi-Homemade approach to cooking, which involves using 70 percent store-bought items and 30 percent homemade items in every meal, makes life easier for millions o read more »
Discuss   Add this link to...  Bury
Bristol-Myers Squibb Company (NYSE: BMY) and PDL BioPharma, Inc. (NASDAQ: PDLI) announced an agreement for the global development and commercialization of PDL BioPharma's anti-CS1 antibody, elotuzum read more »
1 Comment   Add this link to...  Bury
Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc (NYSE: PFE) provided an update on the apixaban clinical development program. The companies announced that new Phase II data in acute coronary s read more »
Discuss   Add this link to...  Bury
I finished my last ImClone Systems vs. Bristol-Myers Squibb entry asking what Bristol had to say about IMCL's claim of a mystery outbidder. Well, yesterday we found out in a press release from BMY. read more »
Discuss   Add this link to...  Bury
Bristol-Myers Squibb posted fourth quarter 2008 net sales from continuing operations of $5.2 billion, an increase of 4%, or 8% excluding foreign exchange impact, compared to the same period in 2007. read more »
Discuss   Add this link to...  Bury
The Bristol-Myers Squibb Foundation has announced funding of more than $1.17 million, focused on hepatitis C prevention and education and the mitigation of the disease in China, India, and Taiwan. Th read more »
Discuss   Add this link to...  Bury